Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition.

Inappropriate activation of the canonical Wnt signaling pathway is associated with progression of hepatocellular carcinoma (HCC). However, the association between the non-canonical pathway activated by Wnt5a and HCC is not well known. The present study investigated the significance of Wnt5a expression in HCC. Immunohistochemical staining of Wnt5a was performed on specimens from 243 patients who underwent hepatic resection for HCC. The present study investigated whether Wnt5a expression was associated with clinical and pathological factors and prognosis. Wnt5a expression in human HCC cell lines was investigated using western blotting. The effects of overexpression or knockdown of Wnt5a were evaluated using proliferation and invasion assays. Changes in epithelial-mesenchymal transition (EMT)-related molecules were investigated using western blotting. Wnt5a negativity was significantly associated with poor tumor differentiation and positive vascular invasion. In univariate analysis, Wnt5a negativity was identified as a significant prognostic factor for overall survival (OS). Multivariate analysis of OS demonstrated that Wnt5a negativity was an independent prognostic factor. Wnt5a expression was lower in HLE and HLF cells than in HepG2 and Huh7 cells. Knockdown of Wnt5a by short hairpin RNA transfection increased the proliferation and invasiveness of Huh7 cells, and decreased the expression levels of E-cadherin. In HLF cells, overexpression of Wnt5a inhibited invasiveness and decreased the expression levels of vimentin. Wnt5a negativity was associated with poor tumor differentiation and positive vascular invasion, and was an independent poor prognostic factor in patients with HCC. Wnt5a may be a tumor suppressor involved in EMT-mediated changes in invasiveness.

[1]  Hai-Yan Min,et al.  Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[2]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[3]  S. Adams,et al.  Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes , 2018, Molecular Cancer Therapeutics.

[4]  Li Zhu,et al.  Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer , 2017, Bioscience reports.

[5]  T. Andersson,et al.  Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance , 2017, European journal of oral sciences.

[6]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[7]  T. Kipps,et al.  Wnt5a Signaling in Normal and Cancer Stem Cells , 2017, Stem cells international.

[8]  T. Andersson,et al.  WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition , 2016, Journal of experimental & clinical cancer research : CR.

[9]  M. Stack,et al.  Wnt5a Signaling in Cancer , 2016, Cancers.

[10]  Zhenbin Zhong,et al.  Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[11]  Y. Suh,et al.  Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. , 2015, Pathology, research and practice.

[12]  L. Qin,et al.  WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis , 2015, Oncotarget.

[13]  Baocun Sun,et al.  Wnt5a Suppresses Colon Cancer by Inhibiting Cell Proliferation and Epithelial–Mesenchymal Transition , 2014, Journal of cellular physiology.

[14]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[15]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[16]  T. Gaasterland,et al.  WNT5A Encodes Two Isoforms with Distinct Functions in Cancers , 2013, PloS one.

[17]  Lei Wang,et al.  Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling. , 2013, Molecular medicine reports.

[18]  S. Semba,et al.  WNT5A is a Key Regulator of the Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties in Human Gastric Carcinoma Cells , 2013, Pathobiology.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  Hui Jiang,et al.  Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. , 2012, World journal of gastroenterology.

[21]  R. Nusse,et al.  Towards an integrated view of Wnt signaling in development , 2009, Development.

[22]  S. Todo,et al.  Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization , 2009, Annals of Surgical Oncology.

[23]  Q. Rao,et al.  Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[24]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[25]  T. Andersson,et al.  Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. , 2005, Cancer research.

[26]  G. Brabant,et al.  Wnt-5a has tumor suppressor activity in thyroid carcinoma , 2005, Oncogene.

[27]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[28]  Li Zhu,et al.  Wnt 5 a promotes epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer Short title : Wnt 5 a promotes EMT and metastasis in NSCLC , 2017 .